Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Matis, S
Title
LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells.
Citation
Hematological oncology; 2022 Feb; 40(1) pg40-47
PubMed ID
34679195
Show Usages
Product Cited
Cross-Reactivity
Applications
200-15
Mouse
in vitro
First Author
Friedrich, C
Title
Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues.
Citation
Nature immunology; 2021 Oct; 22(10) pg1256-1267
PubMed ID
34462601
Show Usages
Product Cited
Cross-Reactivity
Applications
200-12
Mouse
in vitro
212-12
Mouse
in vitro
200-15
Mouse
in vitro
First Author
Giuffrida, L
Title
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Citation
Nature communications; 2021 May 28; 12(1) pg3236
PubMed ID
34050151
Show Usages
Product Cited
Cross-Reactivity
Applications
217-17
Mouse
in vitro
200-02
Mouse
in vitro
200-15
Mouse
in vitro
First Author
Zheng, W
Title
Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL.
Citation
Blood; 2021 Jul 15; 138(2) pg122-135
PubMed ID
33690816
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Mouse
in vitro
200-07
Mouse
in vitro
200-15
Mouse
in vitro
First Author
Herda, S
Title
Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges.
Citation
International journal of cancer; 2021 Jun 15; 148(12) pg3097-3110
PubMed ID
33600609
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Mouse
in vitro
200-07
Mouse
in vitro
200-15
Mouse
in vitro
First Author
Xu, N
Title
STING agonist promotes CAR T cell trafficking and persistence in breast cancer.
Citation
The Journal of experimental medicine; 2021 Feb 1; 218(2)
PubMed ID
33382402
Show Usages
Product Cited
Cross-Reactivity
Applications
200-07
Mouse
in vitro
200-15
Mouse
in vitro
100-21
Mouse
in vitro
211-11B
Mouse
in vitro
300-01A
Mouse
in vitro
216-16
Mouse
in vitro
First Author
Gilfillan, C B
Title
Murine CD8 T-cell functional avidity is stable in vivo but not in vitro: Independence from homologous prime/boost time interval and antigen density.
Citation
European journal of immunology; 2020 Apr; 50(4) pg505-514
PubMed ID
31785153
Show Usages
Product Cited
Cross-Reactivity
Applications
200-15
Mouse
in vitro
First Author
Meng, X
Title
FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells.
Citation
Nature;2018 12 1; 564(7734) pg130-135
PubMed ID
30487606
Show Usages
Product Cited
Cross-Reactivity
Applications
200-02
Human
in vitro
200-07
Human
in vitro
200-10
Human
in vitro
200-15
Human
in vitro
300-02AA
Human
in vitro
300-02BC
Human
in vitro
300-02
Human
in vitro
200-02
Mouse
in vitro
200-07
Mouse
in vitro
200-10
Mouse
in vitro
200-15
Mouse
in vitro
300-02AA
Mouse
in vitro
300-02BC
Mouse
in vitro
315-05
Mouse
in vitro
First Author
Barrow, A D
Title
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.
Citation
Cell; 2018 Jan 25; 172(3) pg534-548.e19
PubMed ID
29275861
Show Usages
Product Cited
Cross-Reactivity
Applications
300-02
Human
in vitro
300-01A
Human
in vitro
200-23
Human
in vitro
200-02
Mouse
in vitro
200-15
Mouse
in vitro
211-11B
Mouse
in vitro
315-05
Mouse
in vitro
315-01A
Mouse
in vitro
First Author
Klein Geltink, R I
Title
Mitochondrial Priming by CD28.
Citation
Cell; 2017 Oct 5; 171(2) pg385-397.e11
PubMed ID
28919076
Show Usages
Product Cited
Cross-Reactivity
Applications
200-15
Mouse
in vitro
210-15
Mouse
in vitro
200-02
Mouse
in vitro
showing 10 of 66
Show More